ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,194 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical IndustryZugKiniksa Pharmaceuticals, GmbH
Kiniksa Pharmaceuticals, GmbH Logo
Verified· 2 sources

Kiniksa Pharmaceuticals, GmbH

Summary

About the company

The core activity of Kiniksa Pharmaceuticals is the development and marketing of biopharmaceutical products, particularly therapeutics for unmet medical needs, with a focus on immunomodulation and cardiovascular diseases. The company concentrates on developing products that target unmet needs and neglected diseases and can offer life-changing treatments.

AI-generated
Offering

Products & services

Industry:Pharmaceutical Industry
✓ Offered
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
6
Arcalyst® (rilonacept)
Arcalyst® (rilonacept) for the treatment of recurrent pericarditis; listed on the website as a marketed prescription medicine with patient, professional and prescribing information.
Clinical Studies
Clinical studies on investigational therapies, in particular a Phase 2/3 study with KPL-387 in recurrent pericarditis; information on the study objective, phase and participation.
Managed Access
Managed Access programmes for investigational or unapproved medicines on a case-by-case basis; includes Compassionate Use, Expanded Access and Named Patient Program for serious diseases without satisfactory alternatives.
Medical Information Resources
Medical information resources for healthcare professionals, including search for product information, medical enquiries, safety reports, reports of adverse events and product complaints related to Arcalyst®.
Congress Materials and Manuscript Publications
Congress materials and manuscript publications for healthcare professionals, with presentations and scientific publications on Arcalyst®, KPL-387, KPL-404, Mavrilimumab and related data.
Patient Support Program (Kiniksa OneConnect™)
Patient support programme with personal support throughout treatment, including assistance with financial options and starting treatment for patients and families.
Comparisons

Kiniksa Pharmaceuticals, GmbH in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Kiniksa Pharmaceuticals, GmbH by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Kiniksa Pharmaceuticals, GmbH to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Grafenaustrasse 5
6300 Zug

At a glance

Legal form
Limited Liability Company
UID
CHE-404.899.773
Founded
2020 · 6 years
Last commercial register change
August 18, 2026
Employees
21 to 50

Knowledge

No knowledge articles yet

Once Kiniksa Pharmaceuticals, GmbH has claimed this profile, we'll publish editorial articles and case studies here together.

Get started

Similar companies

IS
Insmed Switzerland GmbH
Zug
BI
BridgeBio International GmbH
Zug
VP
Vertex Pharmaceuticals (CH) GmbH
Zug
SI
Sarepta International Holdings GmbH
Zug
C(
Cytokinetics (Switzerland) GmbH
Zug
AP
Azurity Pharmaceuticals Switzerland GmbH
Zug
MP
Mirum Pharmaceuticals AG
Zug
AS
Alnylam Switzerland GmbH
Zug